Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
HER-2 Negative Breast Cancer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 20.442.3 million by 2027, registering a CAGR of 10.08% over the forecast period. The emergence of the COVID-19 pandemic had an adverse effect on the world economy and healthcare system. The lockdown all over the ... Read More
-
Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2027 with a CAGR of 11.54% during the forecast period (2022 - 2027). The outbreak of the COVID-19 pandemic had an adverse effect on the global economy and healthcare system. Pharmaceuticals, medical gadgets, and biotechnological ... Read More
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 440,000 diagnosed prevalent cases of esophageal cancer across 16 pharmaceutical markets. Currently there are four leading marketed innovator drugs for the treatment of esophageal cancer, mostly programmed cell death protein 1 (PD1) ... Read More
-
Global Pituitary Cancer Market - 2022-2029
... 9.4% during the forecast period (2022-2029). Pituitary cancer is characterized by abnormal growth in the pituitary gland. It affects the functioning of the pituitary gland and may cause an increased or decreased level of pituitary ... Read More
-
Cancer Diagnostics Market (Test Type: Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy; End-user: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... – Scope of Report TMR’s report on the global cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during ... Read More
-
Global Nasopharyngeal Cancer Market - 2022-2029
... % during the forecast period (2022-2029). Nasopharyngeal cancer is a rare therapy of malignant cancer that appears in the nasopharynx. It is the upper part of the throat behind the nose. The nasopharynx is situated ... Read More
-
Global Chronic Lymphocytic Leukemia Therapeutics Market - 2022-2029
... a CAGR of 7.90% during the forecast period (2022-2029). Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes involved in producing ... Read More
-
Global Cancer Molecular Diagnostics Market - 2022-2029
... CAGR of 6.30% during the forecast period (2022-2029). Cancer molecular diagnostics include the detection, diagnosis, sub-classification, prognosis, and monitoring response to therapy. These techniques identify the alterations in DNA or RNA sequences, associated with cancer. ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market - 2022-2029
... growing at a CAGR of 8.4% during the forecast period (2022-2029). Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. Several risk factors for castration-resistant prostate cancer ... Read More
-
Global Oncology Therapy Market - 2022-2029
... during the forecast period (2022-2029). Cancer therapies are medications designed to limit cancer growth and proliferation by interfering with specific molecules involved in the growth and expansion of malignant cells, such as proteins or DNA. ... Read More
-
Companion Diagnostics for Oncology Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Companion Diagnostics for Oncology market size is growing at a ... Read More
-
Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (Nanoparticles), By Region And Segment Forecasts, 2022 - 2030
... The global nanomedicine market is expected to reach USD 427.18 billion by 2030, registering a CAGR of 11.7% during the forecast period, according to a new report by Grand View Research, Inc. The advantages of ... Read More
-
Global Cervical Cancer Treatment Market - 2022-2029
... cervix is the lower part of the uterus that connects to the vagina. Cervical cancer begins in the cells of the cervix. Most cervical malignancies are caused by strains of the sexually transmitted pathogen, Human ... Read More
-
Global Hematology Market - 2022-2029
... % during the forecast period (2022-2029). Hematology is a branch of medicine that deals with diagnosing, treating, and preventing blood, blood-forming organs, and blood diseases such as blood cancer, anemia, hemophilia, and blood clots. Hematological ... Read More
-
Global Cancer Vaccines Market - 2022-2029
... forecast period (2022-2029). Cancer is a malignant tumor caused by uncontrollable cell development in the body. It can be treated with a variety of drugs and vaccinations. Vaccines are widely classified as either preventative or ... Read More
-
Global Cancer Stem Cells Market - 2022-2029
... stem cells are uncommon immortal cells seen in tumors that give rise to a diverse range of cell types that make up the tumor. These cells have been found in a number of human malignancies ... Read More
-
Global Skin Cancer Market - 2022-2029
... to abnormal growth of skin cells. It is estimated that 90% of skin cancer is caused majorly due to solar and artificial ultraviolet radiation (UV). Ultraviolet radiation is a primary carcinogen that results in UV-induced ... Read More
-
Global Cancer Treatment Drugs Market - 2022-2029
... of 10.6% during the forecast period (2022-2029). The widespread prevalence of cancer leads to the rapid development of cancer treatment drugs. Various drugs have received regulatory approval from the USFDA (Food and Drug Administration) the ... Read More
-
Global Neuroendocrine Cancer Market - 2022-2029
... during the forecast period (2022-2029). Neuroendocrine tumors are tumors that start in specialized neuroendocrine cells. Nerve cells and hormone-producing cells share characteristics with neuroendocrine cells. Market Dynamics The increasing research and development and the growing ... Read More
-
Global Urinary Tract Cancer Market Size study & Forecast, by Cancer Type (Bladder Cancer, Urethral cancer and Ureteric and Renal Pelvic Cancer), Treatment Type (Chemotherapy, and Immunotherapy), and Distribution Channel (Retail Pharmacy, and Online Pharmacy) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Urinary Tract Cancer Market is valued approximately USD 2.02 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.6% over the forecast period ... Read More
-
Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027
... in oncology market size was valued at US$2045 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 23.7% during 2022-2027. The gene therapy in oncology market report provides ... Read More
-
Breast Cancer Drugs Market Size, Share & Trends Report, 2022-2030
... can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Breast Cancer Drugs market size will reach USD million ... Read More
-
Cancer Immunotherapy Market, By Therapy Type (Monoclonal Antibodies, Cancer Vaccines, Immunomodulators, Immune Check Point Inhibitors, and Other Therapy Types), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Lung Cancer, and Other Applications), By End Users (Hospitals and Clinics, Cancer Research Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... (Hospitals and Clinics, Cancer Research Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immunotherapy ... Read More
-
Global Stomach Cancer Treatment Market Size study & Forecast, by Type (Chemotherapy, Radiotherapy, Immunotherapy, Targeted Drug Therapy, Surgery), by End-users (Hospital Pharmacies, Specialty & Retail Pharmacies, Others) and Regional Analysis, 2022-2029
... Market is valued at approximately USD 3.83 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2022-2029. Stomach cancer also commonly known as ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
... Component [Datasets (Clinical, Claims, Pharmacy), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029 The U.S. RWE solutions market is expected to grow at a CAGR of ... Read More
Research Assistance
